Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Sell
15,258
-198
-1% -$22.9K 0.11% 124
2025
Q4
$1.57M Buy
15,456
+1,211
+9% +$114K 0.1% 130
2025
Q3
$1.2M Sell
14,245
-22,419
-61% -$1.85M 0.08% 163
2025
Q2
$2.9M Sell
36,664
-8,873
-19% -$705K 0.21% 83
2025
Q1
$4.09M Sell
45,537
-2,557
-5% -$239K 0.34% 61
2024
Q4
$4.78M Buy
48,094
+20
+0% +$2.06K 0.39% 51
2024
Q3
$5.46M Buy
48,074
+3,970
+9% +$472K 0.45% 45
2024
Q2
$4.99M Buy
44,104
+4,882
+12% +$629K 0.44% 46
2024
Q1
$5.18M Sell
39,222
-2,524
-6% -$311K 0.48% 40
2023
Q4
$4.55M Buy
+41,746
New +$4.33M 0.47% 42
2022
Q4
$8.25M Sell
74,320
-382
-0.5% -$39K 0.95% 19
2022
Q3
$6.43M Buy
+74,702
New +$6.67M 0.78% 22

Other funds holding MRK

Icon Wealth Advisors's MRK Position: Q1 2026 in Review

Icon Wealth Advisors reduced its Merck (MRK) stake by 1.3% in Q1 2026, selling an estimated $22.9K and leaving 15,258 shares worth $1.69M. The position accounts for 0.11% of the portfolio, ranked #124.

Icon Wealth Advisors first reported a position in MRK in Q3 2022 and has held it in 12 quarters since. The position peaked at $8.25M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Icon Wealth Advisors held 15,258 shares of Merck worth $1.69M as of Q1 2026.
  • Icon Wealth Advisors sold 198 Merck shares in Q1 2026, an estimated $22.9K.
  • Merck made up 0.11% of Icon Wealth Advisors's portfolio in Q1 2026, its #124 holding.
  • Icon Wealth Advisors first reported a position in Merck in Q3 2022 and has held it in 12 quarters since.
  • Icon Wealth Advisors's Merck position peaked at $8.25M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Icon Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.